We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Investigators Face Increased Scrutiny From US FDA
Clinical Investigators Face Increased Scrutiny From US FDA
September 15, 2009
As the U.S. Food and Drug Administration (FDA) increases its efforts to discipline clinical investigators, device sponsors should make sure they do not hire investigators who have been disqualified or debarred.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor